- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01308489
Minimally Invasive Surgery in Treating Patients With Spinal Tumors
Comparison of Minimally Invasive Approaches of Spine Tumor Surgery
Studieoversikt
Status
Forhold
Detaljert beskrivelse
PRIMARY OBJECTIVES:
I. Length of operation (operating room [OR] time). II. Estimated blood loss (EBL). III. Complication rate. IV. Neurological preservation.
SECONDARY OBJECTIVES:
I. Motor strength and sensory level (neurological outcome). II. Bladder and bowel function. III. Post-operative pain. IV. Hospital length of stay (recovery time). V. Arthrodesis.
OUTLINE: Patients are randomized to 1 of 2 treatment arms.
ARM I: Patients undergo posterior spinal tumor resection on day 0.
ARM II: Patients undergo anterior and posterior spinal tumor resection on day 0.
After completion of study treatment, patients are followed up for 6 months.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
California
-
Duarte, California, Forente stater, 91010
- City of Hope Medical Center
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Patients must have a diagnosis of primary, secondary or metastatic spine tumor and be undergoing any posterior spinal fusion with or without anterior fusion anywhere from occiput to sacrum
- Greater than 3 month life expectancy
- Women of child-bearing potential must agree to use adequate contraception (hormonal or barrier method of birth control or abstinence) prior to study entry and for six months following duration of study participation; should a woman become pregnant or suspect that she is pregnant while participating on the trial, she should inform her treating physician immediately
- All subjects must have the ability to understand and the willingness to sign a written informed consent
Exclusion Criteria:
- Patients who are not surgical candidates for spine tumor removal, determined by the surgical team
- Patients who have undergone previous spine surgery for tumor removal will be excluded
- Patients with renal cell carcinoma
- As there is an emphasis on blood loss and length of surgery, the critical variable for homogeneity is the vascularity of the tumor; hypervascular spine tumors are regarded by surgeons as amongst the most challenging of cases; by far the three most common hypervascular metastatic tumors are those arising from renal cell carcinoma, thyroid carcinoma and melanoma; these pathologies are usually regarded as a distinct subset for this reason in the majority of studies; because we rarely encounter the later two pathologies in our practice, we chose to include only the former; however, to further homogenize our study population we will exclude all three of the known hypervascular metastatic spine tumors
- Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Arm I (posterior spinal tumor resection)
Patients undergo posterior spinal tumor resection on day 0.
|
Hjelpestudier
Andre navn:
Undergo posterior spinal tumor resection
Undergo anterior and posterior spinal tumor resection
|
Eksperimentell: Arm II (anterior and posterior spinal tumor resection)
Patients undergo anterior and posterior tumor resection on day 0.
|
Hjelpestudier
Andre navn:
Undergo posterior spinal tumor resection
Undergo anterior and posterior spinal tumor resection
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Estimated blood loss (EBL); in milliliters (ml)
Tidsramme: Day 0
|
Will be comparing means with the Wilcoxon test.
|
Day 0
|
Length of operation (OR time)
Tidsramme: Day 0
|
Will be comparing means with the Wilcoxon test.
|
Day 0
|
Complication rate
Tidsramme: Day 0
|
Day 0
|
|
Neurological preservation
Tidsramme: Post operation day 90
|
Post operation day 90
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Length of stay
Tidsramme: Less than 7 days
|
Less than 7 days
|
|
Pain symptoms
Tidsramme: Pre-operation, post-op day 3, discharge, post-op days 7, 28, 60, and 90
|
Pre-operation, post-op day 3, discharge, post-op days 7, 28, 60, and 90
|
|
Assessment of neurologic function using the ASIA (American Spinal Injury Association) Impairment Scale
Tidsramme: Pre-operation, post-op day 3, discharge, post-op days 7, 28, 60, and 90
|
This is an assessment of sensory and motor functions based upon the ASIA Impairment Scale
|
Pre-operation, post-op day 3, discharge, post-op days 7, 28, 60, and 90
|
Evaluation of arthrodesis
Tidsramme: Post-op day 1, 28, and 90
|
Plain x-ray films and CT scans are used to determine the success of arthrodesis (spinal fusion in this case) which is the artificial induction of joint ossification between two bones via surgery.
This is done to relieve intractable pain in a joint which cannot be managed by pain medication.
|
Post-op day 1, 28, and 90
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Rahul Jandial, MD, City of Hope Medical Center
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 10115 (DAIDS-ES)
- NCI-2011-00231 (Registeridentifikator: CTRP (Clinical Trial Reporting Program))
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Neoplasma i ryggmargen hos voksne
-
Seoul National University HospitalFullførtNevrogen blære | Tethered Spinal Cord Syndrome
-
Weill Medical College of Cornell UniversityRekrutteringTethered Cord Syndrome | Bundet snor | Spina Bifida Occulta | Okkult Spina BifidaForente stater
-
Tehran University of Medical SciencesUkjentSvulst | Tethered Cord Syndrome | Fibrolipom av Filum Terminale | Lipomyelomeningocele | Misdannelse av delt ledning | Dermal sinusIran, den islamske republikken
-
University of VirginiaRekrutteringUrologiske sykdommer | Myelomeningocele | Nevrogen blære | Tethered Cord Syndrome | Blære, nevrogen | Nevrologisk dysfunksjonForente stater
Kliniske studier på livskvalitetsvurdering
-
Memorial Sloan Kettering Cancer CenterFullført
-
Latin American Cooperative Oncology GroupRoche Pharma AG; EVA - Grupo Brasileiro de Tumores GinecológicosFullført
-
Maastricht UniversityTNO; Netherlands Instititute for Health Services Research; University of...FullførtHjertefeil | Diabetes mellitus, type 2 | Kronisk obstruktiv lungesykdom | AstmaNederland
-
World Vision CanadaRyerson University; World Health Organization; Global Affairs Canada; Ministry...FullførtDiaré | Malaria | Akutt luftveisinfeksjon
-
University Hospital, Strasbourg, FranceFullførtKirurgisk inngrep | LitenFrankrike
-
King's College LondonGuy's and St Thomas' NHS Foundation TrustFullført
-
Beijing Tsinghua Chang Gung HospitalRekrutteringPostoperative komplikasjoner | Cerebrovaskulær ulykke | Store uønskede hjertehendelser | ModellerKina
-
Federal University of Minas GeraisConselho Nacional de Desenvolvimento Científico e TecnológicoUkjentDepresjon | Muskelsykdommer | Hetetokter | Angst | Premenstruell spenningBrasil
-
Akdeniz UniversityFullført
-
Memorial Sloan Kettering Cancer CenterAvsluttetFamiliene eller pårørende til pasienter behandlet ved MSKCC for ikke-kutane plateepitelkarsinomer i | Øvre fordøyelseskanalForente stater